Join us for a dinner presentation given by Dr. Hatim Husain of Moores of UC San Diego Health on "Managing Patients with KRAS G12C-mutated NSCLC," highlighting LUMAKRAS® (sotorasib), a first-in-class, once-daily oral oncolytic. We'll discuss clinical trial results with a spotlight on best practices in patient biomarker identification, the drug’s dosing guidelines, and adverse event management.
